Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (41-50 of 460) with videos related to

Pageof 46
Sort By:
Immunologic Research|July 15, 2003
A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapyRobert H Vonderheide, Carl H June
Science (New York, N.Y.)|April 19, 2020
Cytokine release syndrome in severe COVID-19John B Moore, Carl H June
Cold Spring Harbor Perspectives in Medicine|October 3, 2012
Novel cell and gene therapies for HIVJames A Hoxie, Carl H June
The New England Journal of Medicine|April 21, 2021
Cytokine Storm. ReplyDavid C Fajgenbaum, Carl H June
Clinical Immunology (Orlando, Fla.)|October 11, 2005
Adoptive immunotherapy: new ways to skin the cat?Michael C Milone, Carl H June
Seminars in Immunology|February 7, 2006
Clinical application of expanded CD4+25+ cellsCarl H June, Bruce R Blazar
Nature Immunology|August 28, 2003
Calcium-independent calcineurin regulationRichard V Parry, Carl H June
Immunological Reviews|December 17, 2013
Engineering T cells for cancer: our synthetic futureRobert H Vonderheide, Carl H June
Blood|December 24, 2011
Predicting cytokine storms: it's about densityMatthew J Frigault, Carl H June
The New England Journal of Medicine|December 2, 2020
Cytokine StormDavid C Fajgenbaum, Carl H June
Pageof 46

Showing results (41-50 of 460) with videos related to

Sort By:
Pageof 46
Immunologic Research|July 15, 2003
A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapyRobert H Vonderheide, Carl H June
Science (New York, N.Y.)|April 19, 2020
Cytokine release syndrome in severe COVID-19John B Moore, Carl H June
Cold Spring Harbor Perspectives in Medicine|October 3, 2012
Novel cell and gene therapies for HIVJames A Hoxie, Carl H June
The New England Journal of Medicine|April 21, 2021
Cytokine Storm. ReplyDavid C Fajgenbaum, Carl H June
Clinical Immunology (Orlando, Fla.)|October 11, 2005
Adoptive immunotherapy: new ways to skin the cat?Michael C Milone, Carl H June
Seminars in Immunology|February 7, 2006
Clinical application of expanded CD4+25+ cellsCarl H June, Bruce R Blazar
Nature Immunology|August 28, 2003
Calcium-independent calcineurin regulationRichard V Parry, Carl H June
Immunological Reviews|December 17, 2013
Engineering T cells for cancer: our synthetic futureRobert H Vonderheide, Carl H June
Blood|December 24, 2011
Predicting cytokine storms: it's about densityMatthew J Frigault, Carl H June
The New England Journal of Medicine|December 2, 2020
Cytokine StormDavid C Fajgenbaum, Carl H June
Pageof 46